期刊文献+

犬血浆中氨氯地平和阿托伐他汀的LC-MS/MS测定 被引量:2

Determination of Amlodipine and Atorvastatin in Dog's Plasma by LC-MS/MS
下载PDF
导出
摘要 建立了LC-MS/MS法同时测定犬血浆中氨氯地平和阿托伐他汀的含量。用甲醇沉淀血样中的蛋白质,采用C18色谱柱,2mmol/L醋酸胺溶液(含0.5%甲酸)-甲醇(32∶68)为流动相,以地西泮为内标,电喷雾离子化,正离子多反应监测,检测离子分别为m/z409.2→m/z238.1(氨氯地平)、m/z559.2→m/z440.5(阿托伐他汀)和m/z285.1→m/z193.1(地西泮)。结果氨氯地平和阿托伐他汀在0.1~20ng/ml和0.2~50ng/ml浓度范围内线性关系良好,定量限为0.1和0.2ng/ml,方法回收率均大于94%,日内、日间RSD均小于9%。 A LC-MS/MS method was established for the determination of amlodipine and atorvastatin in Beagle dog's plasma. The samples were precipitated with methanol. A C18 column was used with the mobile phase of 2 mmol/L ammonium acetate (containing 0.5%formic acid)-methanol (32 : 68). Diazepam was used as the internal standard. ESI was applied and operated in positive ion multiple-reaction monitoring mode. The detected ions were m/z 409.2→ m/z 238.1 (amlodipine), m/z 559.2→ m/z 440.5 (atorvastatin), and m/z 285.1→m/z 193.1 (diazepam). The calibration curves of amlodipine and atorvastatin were linear in the concentration ranges of 0.1 -20 ng/ml and 0.2- 50 ng/ml, and the limit of quantification was 0.1 ng/ml (amlodipine) and 0.2 ng/ml (atorvastatin). The average recoveries were above 94 %. The RSDs of intra- and inter-day were less than 9 %.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2009年第4期295-297,共3页 Chinese Journal of Pharmaceuticals
关键词 氨氯地平 阿托伐他汀 液相色谱-串联质谱 血药浓度 测定 amlodipine atorvastatin LC-MS/MS plasma concentration determination
  • 相关文献

参考文献5

二级参考文献16

  • 1钟大放.以加权最小二乘法建立生物分析标准曲线的若干问题[J].药物分析杂志,1996,16(5):343-346. 被引量:581
  • 2Meredith PA, Eilliott HL. Clinical pharmacokinetics of amlodipine [J]. Clin Pharm, 1992,22(1):22-31.
  • 3Tatar S, Atmaca S. Determination of amlodipine in human plasma by high-performance liquid chromatography with fluorescence detection [J]. J Chromatogr B Biomed Sci Appl, 2001,758:305-310.
  • 4许禄,化学计量学方法,1995年
  • 5萧参,中国药学杂志,1993年,28卷,425页
  • 6Lea AP, McTavish D. Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs,1997,53 (5) :828
  • 7Malhotm HS, Goa KL. Atorvestatin. An updated review of its pharmacological properties and use in dyslipidaemia. Drugs ,2001,61 (12) :1835
  • 8Pouton CW. Lipid formulation for oral administration of drugs: non -emulsifying, self - emulsifying and self - microemulsifying drug delivery systems. Eur J Pharm Sci,2000,11(Suppl 2) :S93
  • 9Jemal M,Ouyang Z,Chen BC,et al. Quantitation of the acid and lactone forms of atorvastatin and its biotransformation products in human serum by high - performance liquid chromatography with electrospray tandem mass spectrometry. Rapid Commun Mats Spectrom, 1999, 13(11) :1003
  • 10Erk N,Altuntas TG. Liquid chromatographic determination of atorvastatin in bulk tiring,tablets,and human plasma. J Liq Chromatogr Relat Technol,2004,27( 1 ) :83

共引文献615

同被引文献18

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部